NURO

NeuroMetrix, Inc. (NURO) | Rumor.io

NeuroMetrix

NURO

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about NURO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% 0

Jul 17

NeuroMetrix, Inc. (NURO) received a $300M commitment from Uber for 20,000 Level 4 self-driving taxis.
The taxis will be produced by Lucid and will be available on the Uber app starting in 2026.
The partnership aims to compete with Waymo and Tesla in the self-driving taxi market.

Generated by AI

Sentiment

Of the messages about NURO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	93.33% +13.33
Bearish	—	—	—	6.67% -13.33

Bullish· Nov 30

$NURO is expected to "explode" and potentially reach $5 or even $7-8 due to strong buying interest and a low float.
The asset has shown a history of price appreciation, with the market likely to find it again once other top performers become exhausted.
Accumulation is underway, with investors buying up the stock, particularly at the $4 price level, and traders anticipating further price increases.

Bearish· Nov 3

The company reported a net loss for the quarter of $1.6 million, or ($0.23) per share.
The stock has fallen to a 52-week low of $1.54, and may continue to decline if it does not hold this level.
The company has a low market capitalization of $11.8 million, and is trading at a price that is lower than its fair market value of $2.50-3.00.

Generated by AI

Topics

Of the messages about NURO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	99.01%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0.99%
Technical Analysis	—	—	—	0%

Earnings· Apr 19

NeuroMetrix, Inc. reported Q1 2018 net income of $1.2 million, a significant improvement from a net loss of $3.2 million in Q1 2017.
Revenue increased 15% year-over-year to $4.9 million in Q1 2018, with the company citing good earnings results.
Despite the positive earnings report, the stock price of NeuroMetrix, Inc. dropped by 7.82% following the release of Q1 2018 results.

Announcements· Oct 7

NeuroMetrix, Inc. ($NURO) has submitted a De Novo request to the FDA for its Quell wearable neuromodulation device to treat fibromyalgia symptoms.
The company expects a commercial launch of Quell in the second half of 2022.
The submission of the De Novo request has led to a significant increase in $NURO stock price, with a 14% rise after hours.

Technical Analysis· Oct 10

$NURO has broken out above the $3.52 resistance level, indicating a potential upward trend.
The stock has formed a consolidation pattern, with a possible breakout imminent, requiring significant volume to confirm.
Technical indicators, including the Relative Strength Index (RSI), suggest that the stock is poised for a potential breakout, with a possible target of filling the next set of gaps up.

Generated by AI

Community

Of the messages about NURO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	4.36%
Newcomers	—	—	—	95.64%

Regulars· Nov 3

$NURO's price has been on a downward trend, and some participants are expecting it to continue, with a possible target of $1.20.
The company's low float and high short float percentage may contribute to its volatility, with some participants expecting it to continue trading in a choppy manner.
$NURO's recent price movement may be influenced by news and announcements, such as the launch of Quell Fibromyalgia, which could impact the company's stock price and trading activity.

Newcomers· Oct 11

Newcomers are focusing on identifying pumps with news that same day, such as recent earnings or offerings, to increase trading potential.
The 52-week low of $NURO has been reached, with the RSI indicating oversold conditions, and many are expecting a bounce in the stock.
Some newcomers are disappointed in missed entry opportunities, citing frustration with not executing trades in a timely manner and being overpowered by emotional "what ifs".

Generated by AI

Also Discussed

Investors talking about NURO also mention

#	Name	Attention
1	Camtek Ltd.CAMT	0%0
2	STAF - Staffing 360 Solutions, Inc.	——
3	YTEN - Yield10 Bioscience, Inc.	——
4	ABIO - ARCA biopharma, Inc.	——
5	Comstock Holding Companies, Inc.CHCI	0%0
6	MediaCo Holding Inc. Class A Common StockMDIA	0%0
7	MTSL - Mer Telemanagement Solutions Ltd.	——
8	New Concept Energy, Inc.GBR	0%0
9	Autohome Inc. ADRATHM	0%new
10	SemiLEDs CorporationLEDS	0%0

NeuroMetrix, Inc.

Location

Social

What share of all stock conversation is about NURO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% 0

Jul 17

NeuroMetrix, Inc. (NURO) received a $300M commitment from Uber for 20,000 Level 4 self-driving taxis.
The taxis will be produced by Lucid and will be available on the Uber app starting in 2026.
The partnership aims to compete with Waymo and Tesla in the self-driving taxi market.

Generated by AI

Sentiment

Of the messages about NURO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	93.33% +13.33
Bearish	—	—	—	6.67% -13.33

Bullish· Nov 30

$NURO is expected to "explode" and potentially reach $5 or even $7-8 due to strong buying interest and a low float.
The asset has shown a history of price appreciation, with the market likely to find it again once other top performers become exhausted.
Accumulation is underway, with investors buying up the stock, particularly at the $4 price level, and traders anticipating further price increases.

Bearish· Nov 3

The company reported a net loss for the quarter of $1.6 million, or ($0.23) per share.
The stock has fallen to a 52-week low of $1.54, and may continue to decline if it does not hold this level.
The company has a low market capitalization of $11.8 million, and is trading at a price that is lower than its fair market value of $2.50-3.00.

Generated by AI

Topics

Of the messages about NURO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	99.01%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0.99%
Technical Analysis	—	—	—	0%

Earnings· Apr 19

NeuroMetrix, Inc. reported Q1 2018 net income of $1.2 million, a significant improvement from a net loss of $3.2 million in Q1 2017.
Revenue increased 15% year-over-year to $4.9 million in Q1 2018, with the company citing good earnings results.
Despite the positive earnings report, the stock price of NeuroMetrix, Inc. dropped by 7.82% following the release of Q1 2018 results.

Announcements· Oct 7

NeuroMetrix, Inc. ($NURO) has submitted a De Novo request to the FDA for its Quell wearable neuromodulation device to treat fibromyalgia symptoms.
The company expects a commercial launch of Quell in the second half of 2022.
The submission of the De Novo request has led to a significant increase in $NURO stock price, with a 14% rise after hours.

Technical Analysis· Oct 10

$NURO has broken out above the $3.52 resistance level, indicating a potential upward trend.
The stock has formed a consolidation pattern, with a possible breakout imminent, requiring significant volume to confirm.
Technical indicators, including the Relative Strength Index (RSI), suggest that the stock is poised for a potential breakout, with a possible target of filling the next set of gaps up.

Generated by AI

Community

Of the messages about NURO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	—	4.36%
Newcomers	—	—	—	95.64%

Regulars· Nov 3

$NURO's price has been on a downward trend, and some participants are expecting it to continue, with a possible target of $1.20.
The company's low float and high short float percentage may contribute to its volatility, with some participants expecting it to continue trading in a choppy manner.
$NURO's recent price movement may be influenced by news and announcements, such as the launch of Quell Fibromyalgia, which could impact the company's stock price and trading activity.

Newcomers· Oct 11

Newcomers are focusing on identifying pumps with news that same day, such as recent earnings or offerings, to increase trading potential.
The 52-week low of $NURO has been reached, with the RSI indicating oversold conditions, and many are expecting a bounce in the stock.
Some newcomers are disappointed in missed entry opportunities, citing frustration with not executing trades in a timely manner and being overpowered by emotional "what ifs".

Generated by AI

NeuroMetrix

Social

Jul 17

Sentiment

Bullish· Nov 30

Bearish· Nov 3

Topics

Earnings· Apr 19

Announcements· Oct 7

Technical Analysis· Oct 10

Community

Regulars· Nov 3

Newcomers· Oct 11

Also Discussed

NeuroMetrix, Inc.

Company Information

Location

Also Discussed

Social

Jul 17

Sentiment

Bullish· Nov 30

Bearish· Nov 3

Topics

Earnings· Apr 19

Announcements· Oct 7

Technical Analysis· Oct 10

Community

Regulars· Nov 3

Newcomers· Oct 11